No Data
No Data
Are GLP-1 Drugs Creating Headwinds for Medical Device Makers?
EU Approves Novo Nordisk's Wegovy for Heart, Stroke Treatment
European Regulatory Authority Adopts a Positive Opinion for an Update of the Wegovy Label to Reflect Risk Reduction of Major Adverse Cardiovascular Events
Eli Lilly Weight Loss Drug Approved in China
Eli Lilly, Novo Extend Muti-day Decline in Rare Selloff
Novo Nordisk, Eli Lilly Fall on Data From Roche's Weight-loss Pill
No Data